| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.005 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.006 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.006 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.006 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.007 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.13 | 0.008 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.09 | 0.009 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.009 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.12 | 0.009 |